← Back to Clinical Trials
Recruiting NCT07066761

Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pelvic Organ Prolapse (POP)
Sponsor A.M.I. Agency for Medical Innovations GmbH
Study Type INTERVENTIONAL
Phase N/A
Enrollment 85
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2025-07-01
Completion 2026-12
Interventions
Laparoscopic lateral suspension with surgical mesh (LatGYNious)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the clinical investigation is to verify that the investigational device (LatGYNious) is appropriate to significantly improve the pelvic organ prolapse in patients.

Eligibility Criteria

Inclusion Criteria: * Symptomatic prolapse in one of the 3 compartments from grade 2 with or without uterus * Subject is candidate for a surgical treatment of pelvic organ prolapse * Subject is willing and able to cooperate with follow-up examinations * Subject has been informed of the study procedures and the treatment and has signed an informed consent form and provided authorization to use and disclose information for research purposes. Exclusion Criteria: * Previous surgical treatment with a mesh implant for pelvic organ prolapse (mesh implant in anterior or posterior compartment) * Active immunotherapy which may negatively affect the treatment with a surgical mesh * Active cancer of the vagina / cervix / rectum * . known or suspected hypersensitivity to Polypropylene * Pregnancy * participation in another study at the same time * Unable to understand study requirements or is unable to comply with follow-up schedule * Contraindicated according to the instruction for use of the devi

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}